Royal Bank of Canada Reaffirms “Outperform” Rating for Pyxis Oncology (NASDAQ:PYXS)
Royal Bank of Canada reiterated their outperform rating on shares of Pyxis Oncology (NASDAQ:PYXS – Free Report) in a report released on Wednesday,Benzinga reports. Royal Bank of Canada currently has a $8.00 price target on the stock. Several other analysts have also commented on PYXS. William Blair lowered shares of Pyxis Oncology from an “outperform” […]
Royal Bank of Canada reiterated their outperform rating on shares of Pyxis Oncology (NASDAQ:PYXS – Free Report) in a report released on Wednesday,Benzinga reports. Royal Bank of Canada currently has a $8.00 price target on the stock. Several other analysts have also commented on PYXS. William Blair lowered shares of Pyxis Oncology from an “outperform” […]
